Yujing Cao - Publications

Short-term effectiveness of visual treatment solution-assisted treatment for Crowe type Ⅲ- Ⅳ developmental dysplasia of the hip

Journal: Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery

Published: May 18, 2026

Exploring the mechanism of Dieda Qili Tablet on fracture healing based on network pharmacology combined with machine learning models.

Journal: Scientific reports

Published: July 25, 2025

Screening of hub genes and immunocytes related to tendon injury based on bioinformatics and machine learning models.

Journal: Scientific reports

Published: March 24, 2025

Astragaloside IV alleviated bone loss in mice with ovariectomy-induced osteoporosis via modulating gut microbiota and fecal metabolism.

Journal: Frontiers in pharmacology

Published: December 19, 2024

Lupeol Alleviates Chondrocytes Senescence in Osteoarthritis by Regulating Autophagy via the Sirtuin 3/Mechanistic Target of Rapamycin Kinase Pathway

Journal: Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition

Published: August 06, 2024

Astragaloside-IV induces the differentiation of bone marrow mesenchymal stem cells into osteoblasts through NMUR2-mediated Wnt/β-catenin pathway.

Journal: Regenerative medicine

Published: May 31, 2023

Astragaloside IV Improves Tibial Defect in Rats and Promotes Proliferation and Osteogenic Differentiation of hBMSCs through MiR-124-3p.1/STAT3 Axis.

Journal: Journal of natural products

Published: January 19, 2021

Mechanism of serotonin-promoted synthesis of osteoblast type I collagen

Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology

Published: December 26, 2015

Epidermal growth factor-like domain 7 promotes endothelial cell migration and angiogenesis by activating ERK signaling pathway

Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology

Published: May 16, 2015

MicroRNA-153 suppresses the osteogenic differentiation of human mesenchymal stem cells by targeting bone morphogenetic protein receptor type II.

Journal: International journal of molecular medicine

Published: November 12, 2014